NeuroMab is an NIH/NINDS-funded monocolonal antibody facility, providing low cost, high quality monoclonal antibodies to the entire neuroscience community. Antibodies are fully validated for biochemical and immunohistochemical applications in mammalian brain, including array tomography. NeuroMab is a cooperative venture among the University of California at Davis, the National Institutes of Health, and Antibodies Inc. Please submit new antibodies requests directly to NeuroMab.
